Temporary sedation with midazolam for control of severe incident pain

scientific article published in May 2001

Temporary sedation with midazolam for control of severe incident pain is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0885-3924(01)00254-8
P8608Fatcat IDrelease_ufj5c2l7hbhd3lzqjsh2b6uxay
P698PubMed publication ID11369164

P2093author name stringOrtega JJ
del Rosario MA
Feria M
Martín AS
P2860cites workBreakthrough pain: definition, prevalence and characteristicsQ33435886
The use of sedative agents in critically ill patientsQ35323911
Terminal restlessness--its management and the role of midazolamQ37393542
Sedation for intractable distress in the dying--a survey of expertsQ39226464
Characterization of breakthrough pain by hospice patients and their caregiversQ39444429
A comparison of the use of sedatives in a hospital support team and in a hospiceQ39445694
Predictive factors in advanced cancer pain treated only by analgesicsQ39500543
Midazolam. A review of its pharmacological properties and therapeutic use.Q40198738
Home palliative care for terminal cancer patients: a survey on the final week of life.Q50143241
Breakthrough pain: characteristics and impact in patients with cancer pain.Q51089873
The use of propofol in palliative medicine.Q51590284
Subcutaneous midazolam infusion in palliative care.Q51729013
The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary reportQ67541948
P433issue5
P921main subjectmidazolamQ423071
P304page(s)439-442
P577publication date2001-05-01
P1433published inJournal of Pain and Symptom ManagementQ6295708
P1476titleTemporary sedation with midazolam for control of severe incident pain
P478volume21

Reverse relations

cites work (P2860)
Q36569562Cancer-related breakthrough pain
Q44105795Dexmedetomidine: a new option for intractable distress in the dying
Q39391702Medication-focused approach to total pain: poor symptom control, polypharmacy, and adverse reactions
Q36586498Sedation for the care of patients with advanced cancer.
Q51237766Self-administered nitrous oxide for the management of incident pain in terminally ill patients: a blinded case series.
Q73261010Similarity and difference among standard medical care, palliative sedation therapy, and euthanasia: a multidimensional scaling analysis on physicians' and the general population's opinions
Q37245357The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland.

Search more.